TDS Pharm participates in Japan Pharmaceutical Expo

TDS Pharm, a company specializing in transdermal drug delivery systems, announced on the 14th that it participated in the Japanese pharmaceutical expo 'CPHI Japan 2025' held in Japan.

CPHI Japan 2025 is an exhibition where pharmaceutical industry professionals from around the world gather to build important partnerships. It opened on the 9th and ran until the 11th. TDS Pharm participated in a joint booth with careplusone, a specialized brokerage trade partner, and went beyond simple product promotion to hold various partnering meetings to expand the pharmaceutical brokerage business.

As a major achievement, we had additional meetings with buyers who signed contracts worth 28 billion won last year and regarding the permit schedule. Through these buyers, we plan to supply products to ▲Uzbekistan ▲Philippines ▲Malaysia ▲Singapore ▲Indonesia ▲Vietnam, etc.

In addition, we have agreed to expand and revise the existing export contract with Saudi Arabian Rx Healthcare, a multinational pharmaceutical distributor, from 5 countries to a total of 15 countries in ▲Middle East Asia ▲North Africa, including ▲Egypt ▲UAE ▲Saudi Arabia ▲Qatar ▲Kuwait ▲Oman ▲South Africa ▲Algeria ▲Libya ▲Morocco, and directly supply them.

We also presented a customized export strategy for each country to supply intermediate products by expanding the supply method from finished pharmaceutical exports to Southeast Asian countries. The intermediate product method can lower the production cost and increase price competitiveness. We completed the registration of the TDS Pharm manufacturing facility with the Philippine FDA in December last year, and through consultation at this exhibition, we agreed to sign this contract in April.

TDS Farm CEO Kim Chul-jun said, “We received a lot of attention at this exhibition as we were able to prove that our quality is on par with that of original patch makers in Japan, the leading country in patch production,” adding, “We have been laying the groundwork for expanding into overseas markets so far, and our export performance will also grow starting in the second half of this year when the permits are completed.”


  • See more related articles